Optimizing  ||| S:0 E:11 ||| VBG
the  ||| S:11 E:15 ||| DT
protection  ||| S:15 E:26 ||| NN
of  ||| S:26 E:29 ||| IN
research  ||| S:29 E:38 ||| NN
participants  ||| S:38 E:51 ||| NNS
and  ||| S:51 E:55 ||| CC
personnel  ||| S:55 E:65 ||| NNS
in  ||| S:65 E:68 ||| IN
HIV-related  ||| S:68 E:80 ||| JJ
research  ||| S:80 E:89 ||| NN
where  ||| S:89 E:95 ||| WRB
TB  ||| S:95 E:98 ||| NN
is  ||| S:98 E:101 ||| VBZ
prevalent ||| S:101 E:110 ||| JJ
:  ||| S:110 E:112 ||| :
practical  ||| S:112 E:122 ||| JJ
solutions  ||| S:122 E:132 ||| NNS
for  ||| S:132 E:136 ||| IN
improving  ||| S:136 E:146 ||| VBG
infection  ||| S:146 E:156 ||| NN
control  ||| S:156 E:164 ||| NN
Tuberculosis  ||| S:164 E:177 ||| NNP
( ||| S:177 E:178 ||| -LRB-
TB ||| S:178 E:180 ||| NN
)  ||| S:180 E:182 ||| -RRB-
is  ||| S:182 E:185 ||| VBZ
a  ||| S:185 E:187 ||| DT
leading  ||| S:187 E:195 ||| JJ
cause  ||| S:195 E:201 ||| NN
of  ||| S:201 E:204 ||| IN
death  ||| S:204 E:210 ||| NN
among  ||| S:210 E:216 ||| IN
persons  ||| S:216 E:224 ||| NNS
with  ||| S:224 E:229 ||| IN
HIV  ||| S:229 E:233 ||| NNP
globally ||| S:233 E:241 ||| NN
.  ||| S:241 E:243 ||| .
HIV-related  ||| S:243 E:255 ||| JJ
research  ||| S:255 E:264 ||| NN
in  ||| S:264 E:267 ||| IN
TB  ||| S:267 E:270 ||| NN
endemic  ||| S:270 E:278 ||| NN
areas  ||| S:278 E:284 ||| NNS
raises  ||| S:284 E:291 ||| VBZ
some  ||| S:291 E:296 ||| DT
unique  ||| S:296 E:303 ||| JJ
and  ||| S:303 E:307 ||| CC
important  ||| S:307 E:317 ||| JJ
ethical  ||| S:317 E:325 ||| JJ
issues  ||| S:325 E:332 ||| NNS
in  ||| S:332 E:335 ||| IN
infection  ||| S:335 E:345 ||| NN
control  ||| S:345 E:353 ||| NN
related  ||| S:353 E:361 ||| VBN
to  ||| S:361 E:364 ||| TO
protecting  ||| S:364 E:375 ||| VBG
both  ||| S:375 E:380 ||| DT
research  ||| S:380 E:389 ||| NN
participants  ||| S:389 E:402 ||| NNS
and  ||| S:402 E:406 ||| CC
personnel ||| S:406 E:415 ||| NNS
.  ||| S:415 E:417 ||| .
To  ||| S:417 E:420 ||| TO
address  ||| S:420 E:428 ||| VB
such  ||| S:428 E:433 ||| JJ
concerns ||| S:433 E:441 ||| NNS
,  ||| S:441 E:443 ||| ,
this  ||| S:443 E:448 ||| DT
article  ||| S:448 E:456 ||| NN
provides  ||| S:456 E:465 ||| VBZ
practical  ||| S:465 E:475 ||| JJ
guidance  ||| S:475 E:484 ||| NN
to  ||| S:484 E:487 ||| TO
help  ||| S:487 E:492 ||| VB
research  ||| S:492 E:501 ||| NN
teams  ||| S:501 E:507 ||| NNS
develop  ||| S:507 E:515 ||| VBP
strategies  ||| S:515 E:526 ||| NNS
to  ||| S:526 E:529 ||| TO
prevent  ||| S:529 E:537 ||| VB
TB  ||| S:537 E:540 ||| NN
transmission  ||| S:540 E:553 ||| NN
in  ||| S:553 E:556 ||| IN
studies  ||| S:556 E:564 ||| NNS
involving  ||| S:564 E:574 ||| VBG
persons  ||| S:574 E:582 ||| NNS
with  ||| S:582 E:587 ||| IN
HIV  ||| S:587 E:591 ||| NNP
in  ||| S:591 E:594 ||| IN
TB  ||| S:594 E:597 ||| NN
endemic  ||| S:597 E:605 ||| NN
settings ||| S:605 E:613 ||| NNS
.  ||| S:613 E:615 ||| .
